Market Tracker

03/27 6:01pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.93
Delayed Data
As of Mar 27
 +0.62 / +4.66%
Today’s Change
6.88
Today|||52-Week Range
16.55
+44.35%
Year-to-Date

Today’s Trading

Previous close13.31
Today’s open13.36
Day’s range13.31 - 14.10
Volume1,233,840
Average volume (3 months)2,006,937
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+10.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+2.06+4.38%
RDUSRadius Health Inc-0.07-0.17%
ESPREsperion Therapeutic...+2.15+2.43%
RLYPRelypsa Inc+0.45+1.34%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts